Michail Alterman

Title: Michail Alterman: Innovator in Antibiotic Development

Introduction

Michail Alterman is a notable inventor based in Lawrence, Kansas, recognized for his contributions to the field of antibiotic development. He has made significant strides in the research of copper-binding compounds, particularly through his innovative work with methanotrophic bacteria.

Latest Patents

Alterman's most recent patent is titled "Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria." This patent describes a means and method for treating bacterial infections while providing antioxidant activity and chelating copper. The compound, known as methanobactin, represents the first of a new class of antibiotics that exhibit gram-positive activity. The structural formula of methanobactin has been sequenced and determined, showcasing its potential in medical applications.

Career Highlights

Throughout his career, Michail Alterman has been associated with prominent research institutions, including the Iowa State University Research Foundation Inc. and the University of Kansas. His work has focused on the intersection of microbiology and medicinal chemistry, leading to groundbreaking discoveries in antibiotic treatments.

Collaborations

Alterman has collaborated with esteemed colleagues such as Hyung J Kim and Cynthia Larive, contributing to a rich environment of innovation and research.

Conclusion

In summary, Michail Alterman is a pioneering inventor whose work on methanobactin has the potential to revolutionize antibiotic treatments. His contributions to science and medicine continue to inspire future research in the field.